Carl Alexander Cohen, v. Boston Scientific Corporation, et al.

2024 DNH 026
District Court, D. New Hampshire·Decided March 26, 2024·No. 20-cv-00943-PB·Published·Cited by 1 cases

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

Carl Alexander Cohen,

v. Case No. 1:20-cv-00943-PB Opinion No. 2024 DNH 026 Boston Scientific Corporation, et al.

MEMORANDUM AND ORDER

The plaintiff, Alex Cohen, underwent surgery for an enlarged prostate

that resulted in diffuse thermal burns to his bladder. He brought a products

liability action against the manufacturer of one of the medical devices used in

his surgery as well as the company that provided the device to the hospital.

The defendants have moved to exclude one of Cohen’s engineering experts

pursuant to Federal Rule of Evidence 702. For the foregoing reasons, the

defendants’ motions to exclude the expert’s testimony (Doc. 69 and Doc. 73)

are denied without prejudice.

I. BACKGROUND

A. The GreenLight XPS Laser System

Boston Scientific Corporation manufactures the GreenLight XPS Laser

System, a medical device used in various surgeries to vaporize and coagulate

tissues. Doc. 69-2 at 16. The device consists of two components: a console,

which generates a green laser light, and a fiber, which transmits the laser light from the console to the targeted tissue in a patient’s body. Id. The laser

light is absorbed by the red blood cells in the targeted tissue, which generates

heat and causes the cells to burst, thereby vaporizing the tissue. Id. at 17.

One type of surgery the GreenLight device can be used for is

photoselective vaporization of the prostate (PVP). Id. at 17, 24. This

procedure is used to treat benign prostatic hyperplasia (BPH), id., a condition

in which a patient’s prostate gland becomes enlarged and squeezes the

urethra, Doc. 82-11 at 4. During a PVP procedure, a laser technician operates

the console, turning it on and placing it on standby mode while the surgeon

prepares for surgery. Doc. 71-3 at 28-29. The surgeon has a bag of saline

solution connected to the laser fiber and adjusts the flow until she and the

laser technician are “happy with the drip rate.” Id. at 27. This saline “runs

through the fiber” throughout the surgery and aids with cooling the fiber. Id.

at 26. The fiber is then inserted into the surgeon’s resectoscope, a surgical

instrument that also includes a camera device as well as a tube for a second,

separate supply of saline solution. Id. at 24, 27; Doc. 71 at 4. The surgeon

inserts the resectoscope into the patient’s bladder via the urethra. Doc. 75 at

1. When she is ready to begin the procedure, she instructs the laser

technician to switch the device off standby mode. Doc. 71-3 at 28. At this

point, the surgeon controls the laser by using a foot switch, which includes

2 pedals to initiate coagulation, vaporization, or standby modes. Id.; Doc. 69-2

at 45.

Throughout the procedure, the surgeon uses the irrigation tube

attached to her resectoscope to “constantly” deliver saline fluid to the surgical

area, controlling the flow using a valve on the resectoscope. Doc. 71-3 at 23,

25. This irrigation helps the surgeon visualize the surgical field by moving

tissues out of the way and flushing away blood and other debris. Id. at 23.

The GreenLight device does not specify the temperature to which this

irrigation fluid should be heated, and surgeons have varying preferences,

electing to use saline heated to either room temperature (approximately 68°F

or 20°C) or just above physiological temperature (around 104°F or 40°C). See

id. at 19; Doc. 71-8 at 17. As the saline circulates through the patient’s

urinary system and is replaced by new irrigant, it is then drained out via a

catheter. Doc. 71-3 at 23; Doc. 75 at 2.

B. Cohen’s Surgery and the Aftermath

In 2016, Cohen saw Dr. Shilpa Lamba, M.D., a board-certified urologist

at Manchester Urology Associates in Dover, New Hampshire, complaining of

“lower urinary tract symptoms.” Doc. 71-3 at 5-7. She diagnosed him with

BPH and, after a year of trying various medications to no avail,

recommended surgical intervention. Id. at 7-8. She presented Cohen with two

options: PVP or transurethral resection of the prostate (TURP). Id. at 8-9. In

3 contrast to PVP, which uses the GreenLight device to vaporize tissue, TURP

uses a surgical instrument containing electrodes—either a monopolar loop or

a bipolar loop—to resect unwanted tissue. Doc. 69 at 3; Doc. 82-2 at 88.

Cohen elected PVP, and Dr. Lamba performed the procedure in July

2017, at Wentworth-Douglass Hospital in Dover, New Hampshire. Doc. 11 at

10; Doc. 75 at 2. She used the GreenLight device and irrigation saline

solution heated to approximately 103 or 104°F, Doc. 71-3 at 19; Doc. 71-5 at

6, to vaporize several sections of enlarged prostate tissue, Doc. 75 at 3. The

surgery proceeded as normal until Dr. Lamba encountered an eight-to-ten-

millimeter nodule at the apex of the prostate that would not vaporize. Doc. 75

at 3. In her attempt to remove this nodule, she “passed the laser fiber

between the nodule and the capsular wall and initiated laser vaporization,”

but the metal cap at the end of the fiber broke off. Id. At this point, one of the

device’s “automatic safety mechanism[s]” activated, and the device switched

back to standby mode. 1 Doc. 71-3 at 29. Dr. Lamba was able to safely retrieve

the fiber’s cap from Cohen’s body but decided to abandon the PVP procedure,

1 This mechanism, known as FiberLife, “continuously monitors the temperature of the tip of the fiber and momentarily stops the laser emission when the fiber gets too hot.” Doc. 69-2 at 16. It is activated if “tissue or vapor bubbles accumulate on the tip [of the fiber], or if for other reasons there is damage due to excessive heating of the fiber.” Id. In “most cases,” the laser will “turn back on immediately and the procedure continues without interruption”; but if FiberLife is “activated continuously,” the console “will automatically detect this condition, [and] put the laser in Standby mode.” Id.

4 switching to the TURP technique and successfully excising the nodule using a

bipolar loop. Doc. 75 at 3.

Towards the end of the surgery, Dr. Lamba inspected the surgical area

for bleeding and evidence of laser vaporization, which has an immediate,

visible effect on the tissue. Id.; Doc. 71 at 5. She documented in her surgical

notes that the ureteral orifices were “away from any vaporization or

resection.” Doc. 75 at 3. She then removed her resectoscope and irrigated the

bladder. Id. All in all, she recorded that Cohen “tolerated the procedure well

with no complications.” Id.

But at a follow-up appointment with Dr. Lamba a few days later,

Cohen reported feeling nauseous and feverish as well as having abdominal

pain. Doc. 11 at 10; Doc. 71-3 at 11-12. Concerned he wasn’t convalescing as

she “would expect after [the] procedure,” Dr. Lamba ordered several tests,

including bloodwork and an ultrasound of the kidneys and bladder. Doc. 71-3

at 12. But before the ultrasound could be conducted, Cohen presented to the

emergency department with persistent symptoms, including “complete[]

incontinen[ce].” Doc. 11 at 10; Doc. 71-3 at 13. He was diagnosed with

hydronephrosis, “a dilation of the collecting system where the urine collects

in the kidneys,” and a urinoma, suggesting “some leakage of urine.” Doc. 71-3

Free access — add to your briefcase to read the full text and ask questions with AI

Carl Alexander Cohen, v. Boston Scientific Corporation, et al., 2024 DNH 026 (D.N.H. 2024).

2024 DNH 026 (Carl Alexander Cohen, v. Boston Scientific Corporation, et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related